BRPI1015472A2 - métodos para prevenção e/ou tratamento de doenças degenerativas do sistema nervoso central - Google Patents

métodos para prevenção e/ou tratamento de doenças degenerativas do sistema nervoso central

Info

Publication number
BRPI1015472A2
BRPI1015472A2 BRPI1015472A BRPI1015472A BRPI1015472A2 BR PI1015472 A2 BRPI1015472 A2 BR PI1015472A2 BR PI1015472 A BRPI1015472 A BR PI1015472A BR PI1015472 A BRPI1015472 A BR PI1015472A BR PI1015472 A2 BRPI1015472 A2 BR PI1015472A2
Authority
BR
Brazil
Prior art keywords
prevention
treatment
methods
nervous system
central nervous
Prior art date
Application number
BRPI1015472A
Other languages
English (en)
Inventor
Gary Lee
Robert Boyd
Original Assignee
Amicus Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amicus Therapeutics Inc filed Critical Amicus Therapeutics Inc
Publication of BRPI1015472A2 publication Critical patent/BRPI1015472A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI1015472A 2009-04-09 2010-04-09 métodos para prevenção e/ou tratamento de doenças degenerativas do sistema nervoso central BRPI1015472A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16810109P 2009-04-09 2009-04-09
PCT/US2010/030470 WO2010118282A1 (en) 2009-04-09 2010-04-09 Methods for preventing and/or treating degenerative disorders of the central nervous system

Publications (1)

Publication Number Publication Date
BRPI1015472A2 true BRPI1015472A2 (pt) 2015-11-24

Family

ID=42934882

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1015472A BRPI1015472A2 (pt) 2009-04-09 2010-04-09 métodos para prevenção e/ou tratamento de doenças degenerativas do sistema nervoso central

Country Status (12)

Country Link
US (1) US8304429B2 (pt)
EP (1) EP2416655B1 (pt)
JP (1) JP5634498B2 (pt)
CN (1) CN102448306B (pt)
AU (1) AU2010233187B2 (pt)
BR (1) BRPI1015472A2 (pt)
CA (1) CA2758187C (pt)
ES (1) ES2505243T3 (pt)
HK (1) HK1168005A1 (pt)
IL (1) IL215584A (pt)
NZ (1) NZ595630A (pt)
WO (1) WO2010118282A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5645918B2 (ja) * 2009-04-09 2014-12-24 アミカス セラピューティックス インコーポレイテッド リソソーム蓄積障害の予防および／または治療方法
HUE028129T2 (en) 2009-10-19 2016-11-28 Amicus Therapeutics Inc New preparations for the prevention and / or treatment of lysosomal storage disorders
WO2011049736A1 (en) 2009-10-19 2011-04-28 Amicus Therapeutics, Inc. Novel compositions for preventing and/or treating degenerative disorders of the central nervous system
WO2012068405A2 (en) 2010-11-17 2012-05-24 Isis Pharmaceuticals, Inc. Modulation of alpha synuclein expression
WO2013070981A2 (en) * 2011-11-08 2013-05-16 University Of Central Florida Research Foundation, Inc. Treating er stress related disorders by stabilizing intracellular calcium homeostasis
US9155695B2 (en) 2013-03-14 2015-10-13 Medtronic, Inc. Injectable ropinirole compositions and methods for making and using same
US9796680B2 (en) 2013-12-23 2017-10-24 Alectos Therapeutics Inc. Glucocerebrosidase modulators and uses thereof
GB201512203D0 (en) 2015-07-13 2015-08-19 Lundbeck & Co As H Agents,uses and methods
US10300155B2 (en) 2015-12-31 2019-05-28 Washington University Alpha-synuclein ligands
CA3036511A1 (en) * 2016-09-12 2018-03-15 Steven Hoffman Compositions for treating dementia
BR112018014281A2 (pt) * 2016-11-15 2018-12-18 H Lundbeck As agentes, usos e métodos para o tratamento da sinucleinopatia
WO2019140231A1 (en) 2018-01-12 2019-07-18 Bristol-Myers Squibb Company Antisense oligonucleotides targeting alpha-synuclein and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69531098T2 (de) * 1994-03-09 2004-04-29 Novo Nordisk A/S Piperidine und pyrrolidine
US20060079533A1 (en) * 2001-03-23 2006-04-13 Nieman James A Methods of treating alzheimer's disease
US6770625B2 (en) 2001-09-07 2004-08-03 Nobex Corporation Pharmaceutical compositions of calcitonin drug-oligomer conjugates and methods of treating diseases therewith
US6670625B1 (en) * 2002-06-18 2003-12-30 Ge Medical Systems Global Technology Company, Llc Method and apparatus for correcting multipole aberrations of an electron beam in an EBT scanner
JP2006507359A (ja) * 2002-10-28 2006-03-02 ノボ・ノルデイスク・エー／エス 心循環器疾患の治療のためのグリコーゲンホスホリラーゼ阻害剤の使用
EP1888068B1 (en) * 2005-06-08 2014-05-21 Amicus Therapeutics, Inc. Treatment of cns disorders associated with mutations in genes encoding lysosomal enzymes
WO2007150064A2 (en) * 2006-06-23 2007-12-27 Amicus Therapeutics, Inc. METHOD FOR THE TREATMENT OF NEUROLOGICAL DISORDERS BY ENHANCING THE ACTIVITY OF β-GLUCOCEREBROSIDASE
US20080009156A1 (en) 2006-07-10 2008-01-10 Malin Glen K System and method for bonding coaxial cable
JP5645918B2 (ja) * 2009-04-09 2014-12-24 アミカス セラピューティックス インコーポレイテッド リソソーム蓄積障害の予防および／または治療方法

Also Published As

Publication number Publication date
EP2416655A4 (en) 2012-09-05
US8304429B2 (en) 2012-11-06
JP5634498B2 (ja) 2014-12-03
NZ595630A (en) 2013-04-26
CA2758187A1 (en) 2010-10-14
AU2010233187B2 (en) 2015-10-08
HK1168005A1 (en) 2012-12-21
EP2416655B1 (en) 2014-06-25
JP2012523430A (ja) 2012-10-04
IL215584A0 (en) 2011-12-29
WO2010118282A1 (en) 2010-10-14
US20100261753A1 (en) 2010-10-14
EP2416655A1 (en) 2012-02-15
ES2505243T3 (es) 2014-10-09
AU2010233187A1 (en) 2011-11-03
IL215584A (en) 2016-11-30
CA2758187C (en) 2017-03-07
CN102448306A (zh) 2012-05-09
CN102448306B (zh) 2014-07-02

Similar Documents

Publication Publication Date Title
BRPI1015472A2 (pt) métodos para prevenção e/ou tratamento de doenças degenerativas do sistema nervoso central
BR112012007950A2 (pt) método para tratar água residual e sistema de tratamento
BRPI1015569A2 (pt) compostos úteis para o tratamento de doenças degenerativas e inflamatórias.
BRPI0717482A2 (pt) Sistema para o tratamento de uma alimentação de hidrocarboneto
BRPI1013705A2 (pt) compostos, composição farmacêutica, método de tratamento de doença ou condição associada com função de trap1 e usos de compostos e de composição farmacêutica
BR112012000422A2 (pt) composto, composição farmacêutica, uso de um composto, e, método para a prevenir tratar ou melhorar doenças do sistema imune
BR112013016535A2 (pt) extratos vegetais para o tratamento e prevenção de infecções
BRPI0807987A2 (pt) Terapia de combinação para tratamento de distúrbios imunes.
BRPI0908026A2 (pt) Métodos para o tratamento de doenças do intestino
BR112014002619A2 (pt) composição farmacêutica e método de tratamento e/ou prevenção de câncer pancreático e combinação farmacêutica
BRPI1008909A2 (pt) métodos e sistema de tratamento de veia
BRPI0921321A2 (pt) métodos para o tratamento de indwcções e tumores
BRPI1014864A2 (pt) "implante de processos espinhosos e métodos associados"
BRPI1013559A2 (pt) compostos, composição farmacêutica, método de tratamento de doença ou condição associada à função trpa1 e respectivos usos
BR112013015870A2 (pt) método para o tratamento de biomassa e sistema
BRPI0911669A2 (pt) sistema e métodos para o aperfeiçoamento da eficiência da disposição de orifício de catéter
FI20095836A (fi) Probioottinen valmiste koirien maha- ja suolistohäiriöiden ennaltaehkäisyyn tai hoitoon
BR112013021984A2 (pt) métodos e sistema de tratamento de poço
BR112013024169A2 (pt) método para o tratamento e prevenção da doença de parkinson
BRPI1009252A2 (pt) composto, pró-droga, composição farmacêutica, métodos para prevenir ou tratar doenças do sistema nervoso central, e mal de alzheimer, e, uso do composto ou de uma pró-droga do mesmo
BR112013013898A2 (pt) compostos de pirimidinona para o uso no tratamento de doenças ou condições mediadas por lp-pla2
BRPI1010517A2 (pt) métodos para prevenção e/ou tratamento de doenças de armazenamento lisossomal
BR112012033536A2 (pt) sistema de esterilização através de chuveiro e método de utilização
BR112012002265A2 (pt) composições farmacêuticas para o tratamento de câncer e outras doenças ou distúrbios
SMT201700105B (it) Nuove composizioni per prevenire e/o trattare disturbi degenerativi del sistema nervoso centrale

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements